Palatin Technologies
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
You can watch PTNT and buy or sell other stocks, ETFs, and their options commission-free!About PTNT
Palatin Technologies, Inc. is a biopharmaceutical company, which engages in the development of medicines based on molecules that modulate the activity of the melanocortin receptor system. Its primary product candidate is marketed under the Vyleesi brand, the trade name for bremelanotide, which is used for the treatment of premenopausal women with acquired, generalized, hypoactive sexual desire disorder (HSDD).
CEOCarl Spana
CEOCarl Spana
Employees30
Employees30
HeadquartersCranbury, New Jersey
HeadquartersCranbury, New Jersey
Founded1986
Founded1986
Employees30
Employees30
PTNT Key Statistics
Market cap4.82M
Market cap4.82M
Price-Earnings ratio-0.09
Price-Earnings ratio-0.09
Dividend yield—
Dividend yield—
Average volume175.07K
Average volume175.07K
High today$0.1094
High today$0.1094
Low today$0.0952
Low today$0.0952
Open price$0.1094
Open price$0.1094
Volume27.43K
Volume27.43K
52 Week high$2.09
52 Week high$2.09
52 Week low$0.035
52 Week low$0.035
People also own
Based on the portfolios of people who own PTNT. This list is generated using Robinhood data, and it’s not a recommendation.